Marshall Wace
TSHA icon

Marshall Wace’s Taysha Gene Therapies TSHA Stock Holding History

Marshall Wace’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-476,865
Closed -$1.56M – 3499
2025
Q3 		$1.56M Buy
476,865
+397,367
+500% +$1.13M ﹤0.01% 1731
2025
Q2 		$184K Buy
+79,498
New +$173K ﹤0.01% 2470
2025
Q1 		– Sell
-138,111
Closed -$239K – 3123
2024
Q4 		$239K Sell
138,111
-347,915
-72% -$722K ﹤0.01% 2301
2024
Q3 		$977K Sell
486,026
-300,068
-38% -$658K ﹤0.01% 1660
2024
Q2 		$1.76M Sell
786,094
-244,563
-24% -$712K ﹤0.01% 1438
2024
Q1 		$2.96M Buy
+1,030,657
New +$2.15M ﹤0.01% 1201
2023
Q1 		– Sell
-69,296
Closed -$157K – 3175
2022
Q4 		$157K Buy
+69,296
New +$140K ﹤0.01% 2730
2022
Q3 		– Sell
-91,670
Closed -$341K – 3892
2022
Q2 		$341K Sell
91,670
-47,716
-34% -$189K ﹤0.01% 2973
2022
Q1 		$909K Buy
139,386
+81,028
+139% +$606K ﹤0.01% 2495
2021
Q4 		$679K Buy
+58,358
New +$880K ﹤0.01% 2651

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return